Clinical Trial Results - Progress in Cancer Care
These summaries highlight recently released results from cancer clinical trials. The findings are significant enough that they are likely to influence your medical care.
The summaries are listed in reverse chronological order. You may also use the navigation tools on the left to search the summaries by keyword or type of cancer.
- Sigmoidoscopy Markedly Reduces Colorectal Cancer Incidence and Mortality
(Posted: 05/11/2010) - A single sigmoidoscopy procedure reduced colorectal cancer incidence and mortality in a large randomized trial published online April 27, 2010, in The Lancet.
- Bortezomib Improves Survival of Newly Diagnosed Patients with Multiple Myeloma
(Posted: 09/11/2008, Updated: 05/04/2010) - The targeted drug bortezomib, when added to standard therapy (melphalan and prednisone), improves survival of patients with newly diagnosed multiple myeloma, according to the May 1, 2010, issue of the Journal of Clinical Oncology.
- Dutasteride Decreases Prostate Cancer Risk
(Posted: 04/12/2010) - Results from a large randomized clinical trial indicate that men at an increased risk for prostate cancer reduced their risk with regular use of the drug dutasteride (Avodart).
- Drug Slows Progression of Cutaneous T-Cell Lymphoma
(Posted: 03/31/2010) - Patients with cutaneous T-cell lymphoma who received the drug denileukin diftitox survived without disease progression for a median of more than 2 years, compared with just over 4 months for patients who received a placebo, according to a study published March 8, 2010, in the Journal of Clinical Oncology.
- Internal Radiation Effectively Reduces Local Recurrence of Some Endometrial Cancers
(Posted: 03/31/2010) - Vaginal brachytherapy was as effective as external-beam radiation therapy at reducing the rate of cancer recurrence in the vagina and had fewer side effects for women with high-intermediate risk endometrial cancer, according to a study published March 6, 2010, in the The Lancet.